Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
Use this LYEL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LYEL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LYEL SEC filings page. Lician reads the product cache first so this HTML stays unique to Lyell Immunopharma Inc even when a live quote feed is slow.
Latest cached year on this hub. Full LYEL income, balance, and cash tables.